This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.
This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.

NEWS

All developments in the becoming of Amatsigroup's future

Amatsigroup acquires Disposable-Lab and enhances its leadership in development services for injectable drug products

Amatsigroup acquires Disposable-Lab and enhances its leadership in development services for injectable drug products Disposable-Lab, a fast-growing French company providing innovative single use technology solutions for aseptic formulation &…
Read more

Amatsigroup acquires Q-Biologicals and strengthens its biologicals offer

Amatsigroup acquires Q-Biologicals and strengthens its offering for international pharmaceutical groups Q-Biologicals, a leading-edge provider of process development and biomanufacturing services Amatsigroup strengthens its position in the d…
Read more

(FR) Chimie Pharma Hebdo - Amatsigroup : «Notre objectif est d’atteindre 50M€ de chiffre d’affaires en 2018»

Sorry, this entry is only available in French.
Read more
You have been succesfully registered
There has been a problem, try again later

Amatsigroup significant events of 2015 and outlook for 2016

Amatsigroup : significant events of 2015 and outlook for 2016 International expansion Reinforcement of R&D activities and operational capacities through two acquisitions: o SEPS Pharma in Belgium o Saint Augustin in France 27% expec…
Read more

Amatsigroup signed a partnership with Pierre Fabre Lab. for the site of Saint Augustin

Pierre Fabre Laboratories have signed with Amatsigroup a strategic partnership agreement for the take over of their pharmaceutical development center St. Augustin in Corrèze (France). French service provider for drug product development for human…
Read more

Amatsigroup acquires Seps Pharma in Belgium

AMATSIGROUP, the leading French supplier of services devoted to the development of both human and veterinary pharmaceutical products, announces the acquisition of Belgian company SEPS Pharma, which provides drug product development services, encompa…
Read more
1 2

CONTACT US

Your message has been sent.

I’m
your name
from
your company,
your region
. I would like to discuss
select a topic
so please
select an option
leave your info
and
leave your message.